About Thalamus Biosciences
Thalamus Biosciences is an imaging science practice. It advises drug discovery teams and imaging and instrument companies on imaging, from the choice of microscope and the design of the assay to screening and validation, and it carries out image analysis as a service. It also advises on the discovery biology around the imaging and provides technical writing.
Lucas Thal, PhD, Founder and Principal Advisor
Lucas is an imaging scientist with drug discovery experience. He has built microscopes and fluorescent probes, run a high-content screening portfolio at a CRO, and led the biology on a pharma program through hit-to-lead. Every Thalamus engagement is carried out by him. Lucas's LinkedIn profile.
Experience
Academic research: Vanderbilt University and Lawrence Berkeley National Lab, 2015 to 2020
Lucas completed a PhD in Chemical Biology at Vanderbilt on single-particle tracking and super-resolution imaging of the dopamine transporter, for which he built the microscopes. At Lawrence Berkeley National Lab he made the fluorescent probes used in that work.
CRO: PhenoVista Biosciences, Scientist II, 2020 to 2021
Lucas ran the high-content screening assay portfolio and led teams on phenotypic assay development and screening across multiple client engagements. He learned what pharma clients ask for.
Pharma: Neurocrine Biosciences, Senior Scientist, 2021 to 2026
Lucas was the lead biologist on a neuroimmunology program through hit-to-lead, and he contributed mechanism-of-action work to one program that reached development-candidate nomination and to a second advancing toward nomination with its full package built. He built iPSC neuron, astrocyte and microglia tri-culture high-content assays and the machine-learning image-analysis pipelines that read them, alongside human whole-blood biomarker assays. He designed and managed CRO studies from the pharma side of the table. He built the internal scientific case for inflammasome biology as a therapeutic axis, and he has target-championing experience in neuroimmunology. He sat on diligence teams that brought in whole programs and assets across disease indications.
Program responsibility
As lead biologist, Lucas was responsible for the scientific question as well as the assays. He set the go/no-go criteria, decided which assays to build and which to outsource, and wrote the study plans that CROs quoted against.
Independence
Thalamus is based in San Diego and does not run a laboratory, so it has no stake in which assay, vendor or CRO a client chooses. It accepts no commission from any CRO or vendor that it recommends. Nothing from a former employer appears in the work for a client, and nothing from a client's program appears anywhere else. The conflicts policy is on the terms page.
The best way to start is an introductory call. If you would prefer to write first, the address is lucas@thalamusbio.com.
Book a 30-minute call You answer a few short questions and choose a time. On the call we discuss your work and the decision you need to make.